Author:

Keywords:

Science & Technology, Life Sciences & Biomedicine, Cardiac & Cardiovascular Systems, Cardiovascular System & Cardiology, Multivessel coronary artery disease, Percutaneous coronary intervention, Acute coronary syndrome, ELEVATION MYOCARDIAL-INFARCTION, ST-SEGMENT ELEVATION, MULTIVESSEL DISEASE, RANDOMIZED-TRIAL, ONLY REVASCULARIZATION, CLINICAL-OUTCOMES, INTERVENTION, VESSEL, ANGIOPLASTY, STRATEGIES, Cardiovascular System & Hematology

Abstract:

Although there is robust evidence that revascularisation of non-culprit vessels should be pursued in patients presenting with an acute coronary syndrome (ACS) and multivessel coronary artery disease (MVD), the optimal timing of complete revascularisation remains disputed. In this systematic review and meta-analysis our results suggest that outcomes are comparable for immediate and staged complete revascularisation in patients with ACS and MVD. However, evidence from randomised controlled trials remains scarce and cautious interpretation of these results is recommended. More non-biased evidence is necessary to aid future decision making on the optimal timing of complete revascularisation.